ReviewFrontiers in nutrition2026
Role of the ketogenic diet in neurodevelopmental disorders: neuroprotection and clinical practice.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurodevelopmental disorders (NDDs), such as autism spectrum disorder (ASD), occur early in life and affect cognitive and behavioral health and motor development. While hereditary factors contribute to the development of ASD, recent research has shown that environmental factors, notably nutritional factors, play important roles in determining the severity and expression of symptoms. The ketogenic diet (KD), a high-fat, low-carbohydrate dietary strategy, has well-established therapeutic significance, particularly in the management of epilepsy. Currently, the KD has recently gained popularity beyond therapeutic treatment, becoming popular as a general health and lifestyle option for healthy people. However, despite its long history, the effects of KD consumption on the development of NDDs are uncertain. This review highlights current literature on the effects of maternal KD on child brain development and NDD development, emphasizing the potential relevance of the KD in treating NDDs. We discuss the therapeutic implications of KD consumption and highlight the known effects of maternal KD on NDD development in children, potentially improving our understanding of NDD treatment. Assessments of the safety of KD and its long-term effects on the developing nervous system should be prioritized in future studies to help evaluate the feasibility, safety, and implementation of the KD in treating NDDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.